Should You Invest In These Stocks? Vericel Corp (VCEL), Supernus Pharmaceuticals Inc (SUPN) and MiMedx Group Inc (MDXG)

Posted by admin March 25, 2015 0 Comment 1505 views

New York, NY – GDP INSIDER  –  03/25/2015.

This article discusses three companies: Vericel Corp (NASDAQ:VCEL), Supernus Pharmaceuticals Inc (NASDAQ:SUPN) and MiMedx Group Inc (NASDAQ:MDXG)

Vericel Corp (NASDAQ:VCEL) posted strong gains of 5.19% or $0.19 yesterday to close at $3.85 on very active trading of 1.876 million shares. The developer of patient specific expanded cellular therapies for severe diseases, started to rally after it released its fourth quarter and full year financial report. Despite losing $2.4 million or $0.17 per diluted share for the fourth quarter, the results were a significant improvement on a year ago, when the loss was $0.97 per diluted share. The earnings also beat the market consensus estimate of a loss of $0.17, making the stock a hold and potential buy.

Can Vericel Corp Continue Posting Gains? Check Out The Technical Indicators With Free VCEL Analysis.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN) started climbing again yesterday after slipping back slightly on Monday with the stock gaining 1.05% or $0.12 to close at $11.58 with more than 1.64 million shares changing hands. The recent rise started last week when the company released its fourth quarter and full year results that showed earnings per diluted share of $0.10, compared to the market consensus estimate of a loss of $0.12 per diluted share. The developer of treatments for the central nervous system is now up 39.52% for the year but with RSI of 71.40 it may be overvalued.

Is Supernus Pharmaceuticals Inc Overvalued? Find Out By Clicking Here For Free SUPN Analysis

MiMedx Group Inc (NASDAQ:MDXG) increased 8.60% or $0.88 yesterday to close at $11.11 on heavy trading of 2.705 million shares, compared to its three month average trading volume of 0.955 million. The developer of regenerative biomaterial products started posting gains after it announced that the Department of Justice had issued a notice that it is declining to prosecute the company in the qui tam action, put forward by the Department of Health and Human Services. With this cloud lifted, the stock may now start to climb higher making it a hold with a view to buy.

Do MiMedx Group Inc’s Fundamentals Support Further Gains? Get The Complete Picture With Free MDXG Analysis.

About UltimateStockAlerts provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit website, for complete risks and disclosures.

Write Your Comment